General Information
Revision date
2022-06-06
Product name
BETNOVATE CL OINTMENT
Product Synonyms
BETNOVATE CL OINTMENT 0,1% / 1% * BETAMETHASONE VALERATE AND CLOTRIMAZOLE, FORMULATED PRODUCT
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
None
Hazard Codes
Hazard statements (CLP)
H411
Hazard statements
Code
Statements
H411
Toxic to aquatic life with long lasting effects
Section 2
EU Classification
Regulation 26/12/2008-27092 as amended Exempt from requirements of EU Dangerous Preparations directive - product regulated as a medicinal product, cosmetic product or medical device. Classification in accordance with Regulation 28848 regarding the Classification, Packaging and Labeling of Substances and Preparations 12/11/2013.
2.1 Classification of the substance or mixture
R52/53
Physical hazards
Not classified.
Health hazards
Not classified.
Environmental hazards
Hazardous to the aquatic environment, Category 2
2.2 Label elements
Labeling in accordance with Regulation 28848 regarding the Classification, Packaging and Labeling of Substances and Preparations 11/12/2013
Contains
BETAMETHASONE VALERATE, Paraffin wax
Signal word
None.
Hazard statements
H411 Toxic to aquatic life with long lasting effects.
Prevention
P273 Avoid release to the environment.
Response
P312 Call the NATIONAL TOXICITY INFORMATION CENTRE at 114 or a doctor/ physician if you feel unwell. P391 Collect spillage.
Storage
Not available.
Disposal
P501 Dispose of contents/container (in accordance with related regulations).
Additional information
1 % of the mixture consists of component(s) of unknown acute dermal toxicity.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards. This product will support combustion.
